Skip to main content

Table 2 Tumor-associated antigens for generation of rFc fusion proteins

From: Longitudinal autoantibody responses against tumor-associated antigens decrease in breast cancer patients according to treatment modality

Gene Accession # Signal Sequence Amino Acids Encoded Amino Acid Fragment
20 Original Antigens    
 ANGPTL4 NM_139314 1–30 31–406
 CD147 NM_198589 1–21 22–162
 CD320 NM_016579 1–46 47–230
 CDH3 NM_001793 1–24 25–654
 CST2 NM_001322 1–20 21–141
 DKK1 NM_012242 1–28 29–266
 EPHA2 NM_004431 1–26 27–535
 GFRA1 AF038421 1–24 25–465
 GRN NM_002087 1–17 18–593
 ERBB2 NM_004448 1–22 23–652
 IGFBP2 NM_000597 1–39 40–328
 LAMC2 NM_005562 1–21 22–1111
 LGALS1 NM_002305 1–17 18–135
 LRP10 NM_014045 1–16 17–440
 LRRC15 NM_001135057 1–27 28–544
 MUC1 NM_002456 1–22 23–167
 SPINT2 NM_021102 1–27 28–198
 SPON2 NM_012445 1–26 27–331
 SSR2 NM_003145 1–17 18–146
 SUSD2 NM_019601 1–27 28–785
12 Additional Antigens    
 A1AT NM_000295.4 1–24 25–418
 AMACR NM_014324.5 None 1–382
 BIRC5 NM_001168.2 None 1–142
 CALD1 NM_033139.3 None 1–558
 CAPC NM_001013653.2 1–26 27–264
 CCNB1 NM_031966.3 None 1–433
 CCND1 NM_053056.2 None 1–295
 GRP78 NM_005347.4 None 1–654
 LGALS3 NM_002306.3 None 1–250
 MYC NM_002467.4 None 1–439
 NY-ESO-1 NM_001327.2 None 1–180
 XAGE1 NM_001097594.2 None 1–81